International Journal of Endocrinology

International Journal of Endocrinology / 2017 / Article

Corrigendum | Open Access

Volume 2017 |Article ID 8165368 | https://doi.org/10.1155/2017/8165368

Amilton Dos Santos-Júnior, Taciane Barbosa Henriques, Maricilda Palandi de Mello, Osmar Henrique Della Torre, Lúcia Arisaka Paes, Adriana Perez Ferreira-Neto, Letícia Esposito Sewaybricker, Thiago Salum Fontana, Eloisa Helena Rubello Valler Celeri, Gil Guerra-Júnior, Paulo Dalgalarrondo, "Corrigendum to “Pharmacogenetics of Risperidone and Cardiovascular Risk in Children and Adolescents”", International Journal of Endocrinology, vol. 2017, Article ID 8165368, 1 page, 2017. https://doi.org/10.1155/2017/8165368

Corrigendum to “Pharmacogenetics of Risperidone and Cardiovascular Risk in Children and Adolescents”

Received05 Jan 2017
Accepted19 Apr 2017
Published16 May 2017

In the article titled “Pharmacogenetics of Risperidone and Cardiovascular Risk in Children and Adolescents” [1], there was an error in the “Laboratory Evaluation” section, where the selected CYP2D6 SNP is written as rs72552269, and should be corrected to “rs1065852.”

References

  1. A. D. Santos-Júnior, T. B. Henriques, M. P. de Mello et al., “Pharmacogenetics of risperidone and cardiovascular risk in children and adolescents,” International Journal of Endocrinology, vol. 2016, Article ID 5872423, 10 pages, 2016. View at: Publisher Site | Google Scholar

Copyright © 2017 Amilton Dos Santos-Júnior et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder
Views601
Downloads262
Citations

Related articles